Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × NIH × BNT162 Vaccine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Specimen Handling 113 Magnetic Resonance Spectroscopy 76 Biopsy 67 Cyclophosphamide 22 pembrolizumab 20 fludarabine 17 Cisplatin 17 Nivolumab 15 Taxes 14 Platinum 14 1,2-diaminocyclohexaneplatinum II citrate 14 venetoclax 13 Paclitaxel 13 Immunoglobulin G 13 Disulfides 13 X-Rays 12 Radiation 11 Carboplatin 11 Doxorubicin 10 Radiotherapy 9 Gemcitabine 9 aldesleukin 8 Prednisone 8 olaparib 7 durvalumab 7 atezolizumab 7 trastuzumab deruxtecan 6 lutetium Lu 177 dotatate 6 gallium Ga 68 dotatate 6 decitabine and cedazuridine drug combination 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05170399 2026-02-05

Vaccine Responses in Patients With B Cell Malignancies

National Institutes of Health Clinical Center (CC)

Phase 4 Recruiting

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡